Abstract
The complex nature of the bone complicates its reconstruction and arises the use of biomaterials for this purpose. The materials should have similar properties with the bone and can be used in different application. Particularly, beta-tricalcium phosphate (β-TCP) and hydroxyapatite (HAp) are biocompatible, bioactive, and osteoconductive materials having similar properties with the bone. In this review, the applications of tricalcium phosphate and hydroxyapatite in orthopedics are given in terms of graft, carrier, and coating materials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chu PK, Liu X. Biomaterials fabrication and processing handbook. Boca Raton: CRC Press; 2008.
Kankilic B. Analysis of the effects of vancomycin containing bioceramic/polymer composites on biofılm prevention, biocompatibility and osteogenic modification of mesenchymal stem cells. Thesis of Philosophy of Doctorate in Biotechnology, Middle East Technical University, Ankara Turkey, September 2015.
Nath S, Basu B, Sinha A. A comparative study of conventional sintering with microwave sintering of hydroxyapatite synthesized by chemical route trends. Biomater Artif Organs. 2006;19(2):93–8.
Thamaraiselvi TV, Rajeswari S. Biological evaluation of bioceramic materials – a review. Trends Biomater Artif Organs. 2004;18(1):9–17.
Amy J, Johnson W, Herschler BA. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater. 2011;7(1):16–30.
Mehdikhani B, Borhani GH. Synthesis nano bio-ceramic powder β-Ca2P2O7. J Ceram Process Res. 2015;16(3):308–12.
Mirhadi B, Mehdikhani B, Askari N. Synthesis of nano-sized β-tricalcium phosphate via wet precipitation. Proc Appl Ceram. 2011;5(4):193–8.
Kankilic B, Bayramli E, Kilic E, Dagdeviren S, Korkusuz F. Vancomycin containing PLLA/b-TCP controls MRSA in vitro. Clin Orthop Relat Res. 2011;469:3222–8.
Kannan S, Goetz-Neunhoeffer F, Neubauer J, Pina S, Torres PMC, Ferreira JMF. Synthesis and structural characterization of strontium -and magnesium-co-substituted b-tricalcium phosphate. Acta Biomater. 2010;6:571–6.
Dessi M, Borzacchiello A, Mohamed THA, Abdel-Fattah WI, Ambrosio L. Novel biomimetic thermosensitive b-tricalcium phosphate/chitosan-based hydrogels for bone tissue engineering. J Biomed Mater Res Part A. 2013;101A:2984–93.
Daculsi G, Goyenvalle E, Cognet R, Aguado E, Suokas EO. Osteoconductive properties of poly(96L/4D-lactide)/beta-tricalcium phosphate in long term animal model. Biomaterials. 2011;32:3166–77.
Bin Liu PD, Deng-xing Lun MSC. Current application of b-tricalcium phosphate composites in orthopaedics. Orthop Surg. 2012;4:139–44.
Zhang X, Cai Q, Liu H, Zhang S, Wei Y, Yang X, Lin Y, Yang Z, Deng X. Calcium ion release and osteoblastic behavior of gelatin/beta-tricalcium phosphate composite nanofibers fabricated by electrospinning. Mater Lett. 2012;73:172–5.
Damlar I, Erdogan O, Tatli U, Arpag OF, Gormez U, Ustun Y. Comparison of osteoconductive properties of three different b-tricalcium phosphate graft materials: a pilot histomorphometric study in a pig model. J Craniomaxillofac Surg. 2015;43:175–80.
Cao H, Kuboyama N. A biodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering. Bone. 2010;46:386–95.
Lee JH,Ryu MY, Baek H, Lee K, Seo JH, Lee HK. Fabrication and evaluation of porous beta-tricalcium phosphate/hydroxyapatite (60/40) composite as a bone graft extender using rat calvarial bone defect model. Sci World J. 2013;2013:481789. 9.
Cao L, Duan PG, Wang HR, Li XL, Yuan FL, Fan ZY, Li SM, Dong J. Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized b-tricalcium phosphate scaffold. Int J Nanomedicine. 2012;7:5881–8.
Zhao XF, Li XD, Kang YQ, Yuan Q. Improved biocompatibility of novel poly(L-lactic acid)/b-tricalcium phosphate scaffolds prepared by an organic solvent-free method. Int J Nanomedicine. 2011;6:1385–90.
Castilho M, Rodrigues J, Pires I, Gouveia B, Pereira M, Moseke C, Groll J, Ewald A, Vorndran E. Fabrication of individual alginate-TCP scaffolds for bone tissue engineering by means of powder printing. Biofabrication. 2015;7:015004.
Kankilic B, Bilgic E, Korkusuz P, Korkusuz F. Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo. J Orthop Surg Res. 2014;9:114.
Ahola N, Veiranto M, Männistö N, Karp M, Rich J, Efimov A, Kellomäki M. Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis. Biomatter. 2012;2(4):213–25.
Makarov C, Berdicevsky I, Raz-Pasteur A, Gotman I. In vitro antimicrobial activity of vancomycin-eluting bioresorbable β-TCP-polylactic acid nanocomposite material for load-bearing bone repair. J Mater Sci Mater Med. 2013;24(3):679–87.
Xie XH, Wang XL, Zhang G, He YX, Leng Y, Tang TT, Qin L. Biofabrication of a PLGA–TCP-based porous bioactive bone substitute with sustained release of icaritin. J Tissue Eng Regen Med. 2015;9(8):961–72.
Vahabzadeh S, Edgington J, Bose S. Tricalcium phosphate and tricalcium phosphate/polycaprolactone particulate composite for controlled release of protein. Mater Sci Eng C. 2013;33(7):3576–82.
Kundu B, Nandi SK, Roy S, Dandapat N, Soundrapandian C, Datta S, Basu D. Systematic approach to treat chronic osteomyelitis through ceftriaxone–sulbactam impregnated porous β-tri calcium phosphate localized delivery system. Ceram Int. 2012;38(2):1533–48.
Zhou J, Fang T, Wang Y, Dong J. The controlled release of vancomycin in gelatin/b-TCP composite scaffolds. J Biomed Mater Res Part A. 2012;100A:2295–301.
Seidenstuecker M, Mrestani Y, Neubert RH, Bernstein A, Mayr HO. Release kinetics and antibacterial efficacy of microporous β-TCP coatings. J Nanomater. 2013;2013:13.
Sohier J, Daculsi G, Sourice S, De Groot K, Layrolle P. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J Biomed Mater Res A. 2010;92(3):1105–14.
Mina A, Caicedo HH, Uquillas JA, Aperador W, Gutiérrez O, Caicedo JC. Biocompatibility behavior of β–tricalcium phosphate-chitosan coatings obtained on 316L stainless steel. Mater Chem Phys. 2016;175:68–80.
Chen M, Le DQ, Kjems J, Bünger C, Lysdahl H. Improvement of distribution and osteogenic differentiation of human mesenchymal stem cells by hyaluronic acid and β-tricalcium phosphate-coated polymeric scaffold in vitro. Bio Res Open Access. 2015;4(1):363–73.
Chai H, Guo L, Wang X, Gao X, Liu K, Fu Y, Yang K. In vitro and in vivo evaluations on osteogenesis and biodegradability of a β-tricalcium phosphate coated magnesium alloy. J Biomed Mater Res A. 2012;100(2):293–304.
Fox K, Tran PA, Tran N. Recent advances in research applications of nanophase hydroxyapatite. ChemPhysChem. 2012;13:2495–506.
Zakaria SM, Sharif Zein SH, Othman MR, Yang F, Jansen JA. Tissue Eng, Part B Rev. 2013;19(5):431–41.
Chavan PN, Bahir MM, Mene RU, Mahabole MP, Khairnar RS. Study of nanobiomaterial hydroxyapatite in simulated body fluid: formation and growth of apatite. Mater Sci Eng B. 2010;168:224–30.
Akram M, Ahmed R, Shakir I, et al. Extracting hydroxyapatite and its precursors from natural resources. J Mater Sci. 2014;49:1461.
Wu S-C, Hsu H-C, Hsu S-K, Chang Y-C, Ho W-F. Synthesis of hydroxyapatite from eggshell powders through ball milling and heat treatment. J Asian Ceramic Soc. 2016;4(1):85–90.
Tas CA, Korkusuz F, Timucin M, Akkas N. (1997). An investigation of the chemical synthesis and high-temperature sintering behaviour of calcium hydroxyapatite (HA) and tricalcium phosphate (TCP) bioceramics. J Mater Sci Mater Med. 1997;8(2):91–6.
Çiftci E, Kose S, Korkusuz P, Timucin M, Korkusuz F. Boron containing nano hydroxyapatites (B-n-HAp) stimulate mesenchymal stem cell adhesion, proliferation and differentiation. Key Eng Mater. 2015;631:373–8.
Korkusuz F, Korkusuz P. Use of hydroxyapatite ceramics in orthopedics. Acta Orthop Traumatol Turc. 1997;31:63–7.
Ding Z, Fan Z, Huang X, Lu Q, Xu W, Kaplan DL. Silk-hydroxyapatite nanoscale scaffolds with programmable growth factor delivery for bone repair. ACS Appl Mater Interfaces. 2016;8(37):24463–70.
Parent M, Magnaudeix A, Delebassée S, Sarre E, Champion E, Viana Trecant M, Damia C. Hydroxyapatite microporous bioceramics as vancomycin reservoir: antibacterial efficiency and biocompatibility investigation. J Biomater Appl. 2016;31(4):488–98.
Huang D, Zuo Y, Zou Q, Zhang L, Li J, Cheng L, Shen J, Li Y. Antibacterial chitosan coating on nano-hydroxyapatite/polyamide66 porous bone scaffold for drug delivery. J Biomater Sci Polymer Edition. 2011;22(7):931–44.
Dasgupta S, Banerjee SS, Bandyopadhyay A, Bose S. Zn- and Mg-doped hydroxyapatite nanoparticles for controlled release of protein. Langmuir. 2010;26:4958–64.
Tavakoli-darestani R, Manafi-rasi A, Kamrani-rad A. Dexamethasone-loaded hydroxyapatite enhances bone regeneration in rat calvarial defects. A Mol Biol Rep. 2014;41:423. doi:10.1007/s11033-013-2876-9.
Lozano D, Sánchez-Salcedo S, Portal-Núñez S, Vila M, López-Herradón A, Ardura JA, Mulero F, Gómez-Barrena E, Vallet-Regí M, Esbrit P. Parathyroid hormone-related protein (107-111) improves the bone regeneration potential of gelatin–glutaraldehyde biopolymer-coated hydroxyapatite. Acta Biomater. 2014;10:3307–16.
Suchı T, Šupová M, Klapková E, Hornı L, Rıglová S, Žaloudková M, Braun M, Sucharda Z, Ballay R, Veselı J, Chlup H, Denk F. The sustainable release of vancomycin and its degradation products from nanostructured collagen/hydroxyapatite composite layers. J Pharm Sci. 2016;105:1288e1294.
Sirin HT, Vargel I, Kutsal T, Korkusuz P, Piskin E. Ti implants with nanostructured and HA-coated surfaces for improved osseointegration. Artif Cells, Nanomed Biotechnol. 2016;44(3):1023–30. doi:10.3109/21691401.2015.1008512.
Eto S, Kawano S, Someya S, Miyamoto H, Sonohata M, Mawatari M. First clinical experience with thermal sprayed silver oxide-containing hydroxyapatite coating implant. J Arthroplast. 2016; doi:10.1016/j.arth.2015.12.034.
Patel A, Ghai A, Anand A. Clinical benefit of hydroxyapatite-coated versus uncoated external fixation: a systematic review. Int J Orthod. 2016;183(3):581–590. 2313–1462. doi:10.17554/j.issn.2313-1462.2016.03.163.
Li K, Shen Q, Xie Y, You M, Huang L, Zheng X. Incorporation of cerium oxide into hydroxyapatite coating regulates osteogenic activity of mesenchymal stem cell and macrophage polarization. J Biomater Appl. 2016;31(7):1–15.
Gryshkov O, Klyui NI, Temchenko VP, Kyselov VS, Chatterjee A, Belyaev AE, Lauterboeck L, Iarmolenko D, Glasmacher B. Porous biomorphic silicon carbide ceramics coated with hydroxyapatite as prospective materials for bone implants. Mater Sci Eng C. 2016;68:143–52.
Lee JH, Jang HL, Lee KM, Baek H-R, Jin K, Noh JH. Cold-spray coating of hydroxyapatite on a three-dimensional polyetheretherketone implant and its biocompatibility evaluated by in vitro and in vivo minipig model. J Biomed Mater Res Part B Appl Biomater. 2017;105:647–57.
Tao ZS, Zhou WS, He XW, Liu W, Bai BL, Zhou Q, Huang ZL, Tu KK, Li H, Sun T, Lv YX, Cui W, Yang L. A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater Sci Eng C. 2016;62:226–32.
Yoshii T, Hirai T, Sakai K, Sotome S, Enomoto M, Yamada T, Inose H, Kato T, Kawabata S, Okawa A. Anterior cervical corpectomy and fusion using a synthetic hydroxyapatite graft for ossification of the posterior longitudinal ligament. Orthopedics. 2016; doi:10.3928/01477447-20161208-02.
Uemura K, Kanamori A, Aoto K, Yamazaki M, Sakane M. Novel unidirectional porous hydroxyapatite used as a bone substitute for open wedge high tibial osteotomy. J Mater Sci Mater Med. 2014;25:2541–7. doi:10.1007/s10856-014-5266-5.
Minami M, Takechi M, Ohta K, Ohta A, Ninomiya Y, Takamoto M, Fukui A, Tada M, Kamata N. Bone formation and osseointegration with titanium implant using granular- and block-type porous hydroxyapatite ceramics (IP-CHA). Dent Mater J. 2013;32(5):753–60.
Fu K, Xu Q, Czernuszka J, Triffitt JT, Xia Z. Characterization of a biodegradable coralline hydroxyapatite/calcium carbonate composite and its clinical implementation. Biomed Mater. 2013;8(6):065007. doi:10.1088/1748-6041/8/6/065007.
Kim BS, Kang HJ, Yang SS, Lee J. Comparison of in vitro and in vivo bioactivity: cuttlefish-bone-derived hydroxyapatite and synthetic hydroxyapatite granules as a bone graft substitute. Biomed Mater. 2014;9(2):025004. doi:10.1088/1748-6041/9/2/025004.
Iundusi R, Gasbarra E, D’Arienzo M, Piccioli A, Tarantino U. Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENTTM. Three-year follow-up from a prospective study. BMC Musculoskelet Disord. 2015;16:115.
Borkowski L, Pawłowska M, Radzki RP, Bieńko M, Polkowska I, Belcarz A, Karpiński M, Słowik T, Matuszewski Ł, Ślósarczyk A, Ginalska G. Effect of a carbonated HAP/β-glucan composite bone substitute on healing of drilled bone voids in the proximal tibial metaphysis of rabbits. Mater Sci Eng C Mater Biol Appl. 2015;53:60–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kankilic, B., Dede, E.C., Korkusuz, P., Timuçin, M., Korkusuz, F. (2017). Apatites for Orthopedic Applications. In: Kaur, G. (eds) Clinical Applications of Biomaterials. Springer, Cham. https://doi.org/10.1007/978-3-319-56059-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-56059-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56058-8
Online ISBN: 978-3-319-56059-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)